Search Results

You searched for : FDANews  

FDA approval for Moderna's Covid-19 vaccine

Latest Corporate News ; Pharma...
Feb 01

Novavax applies for FDA emergency use authorization of its coronavirus vaccine

Latest Corporate News; Pharma Jan1st/2022...
Feb 01

FDA clears MindMed IND for MM-120 in treatment of generalized anxiety disorder

FDA clearance leads to first commercial INDfor LSD, enabling initiation of Phase 2b dose-optimization trials of MM-120 in early 2022 - ...
Jan 31

SOM Biotech granted orphan drug designation by the FDA for SOM3355

Latest FDA approval news...
Oct 20

FDA approves Abbott's Amplatzer Talisman System for PFO Closure in people at risk of recurrent Stroke

Latest Pharma News update...
Oct 04

U.S. FDA approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus

Indicated for patients with Alagille Syndrome one year of age and older...
Oct 04

ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma

Latest pharma news update...
Oct 04

Versantis Receives U.S. FDA Orphan Drug Designation for VS-01

Latest pharma news updates...
Sep 13

Versantis receives U.S. FDA orphan drug designation for VS-01

Latest pharma news updates...
Sep 09

Poseida Therapeutics announces FDA clearance of investigational new drug application for P-BCMA-ALLO1,

The new drug is an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma...
Sep 03

PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Amyotrophic Lateral Sclerosis

Latest Pharma News Update...
Aug 07

Alkermes Receives FDA fast track designation for Nemvaleukin Alfa for the treatment of Mucosal Melanoma

FDA News Update...
Aug 05

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ...
Jul 30

FDA Clearance of IND for FPI-1966, Radiopharmaceutical for Head and Neck and Bladder Cancers Expressing FGFR3

Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ...
Jul 30

Pfizer provides update on U.S. FDA review of Abrocitinib and XELJANZ filings

Pharma News update...
Jul 23

Sanofi extends collaboration with Genedata for Pharmaceutical Development & Manufacturing Science

Latest FDA approvals update...
Jul 16

Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL.

New approval for treating leukomia...
Jun 22

Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing for Coronavirus

Roche SARS-CoV-2 molecular test for PCR testing is effective for both symptomatic and asymptomatic Covid individuals ...
Jun 22

Novartis receives FDA approval 177Lu-PSMA-617 for metastatic castration resistant prostate cancer

FDA breakthrough therapy for Novartis metastatic prostate cancer drug ...
Jun 21

FDA authorizes monoclonal antibody therapy for emergency use in some patients 12 and older

The authorization is specifically for those with mild-to-moderate Covid-19, who are at risk of getting much sicker...
May 27

Boehringer Ingelheim's Investigational Treatment for Schizophrenia receives FDA Breakthrough Therapy Designation

The company also announced the planned initiation of the innovative CONNEX Phase III clinical trial program assessing the safety and efficacy of BI 425809 ...
May 27

FDA Emergency Use Authorization Approval for ZEUS ELISA SARS-CoV-2 Total Antibody Test System

Now ELISA bases Covid test from Zeus Scientific...
May 19

US bans menthol and other flavored cigarettes

CDC bans all flavored cigarettes...
Apr 30

Sorrento receives FDA clearance Phase 2 study for Sti-3031 ; Advanced Urothelial Carcinoma

Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform...
Apr 28

FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker

GSK gets FDA nod for Jemperli indicated for endometrial cancer...
Apr 26

25 Matching result(s) found!